fibula 发表于 2025-3-30 11:41:05

http://reply.papertrans.cn/71/7052/705194/705194_51.png

相符 发表于 2025-3-30 14:40:39

Potential and Limitations in Early Diagnosis of Ovarian Cancerhe last decade (2, 3). However, using these markers to detect ovarian cancer early enough to reduce mortality remains challenging because screening needs to identify cancer before symptoms occur, early enough that the disease is still curable. It is well established that the best screening tests det

idiopathic 发表于 2025-3-30 19:56:22

http://reply.papertrans.cn/71/7052/705194/705194_53.png

artifice 发表于 2025-3-30 21:05:02

Classification of Ovarian Cancer: A Genomic Analysishese histotypes resemble various müllerian cell types, with serous tumors resembling Fallopian tube, endometrioid tumors resembling uterine endometrium, mucinous tumors resembling the endocervix, and clear cell tumors resembling endometrial glands during pregnancy (2). Tumors are graded from 1 to 3,

阻挠 发表于 2025-3-31 03:02:31

http://reply.papertrans.cn/71/7052/705194/705194_55.png

香料 发表于 2025-3-31 07:13:26

http://reply.papertrans.cn/71/7052/705194/705194_56.png

strain 发表于 2025-3-31 12:17:34

http://reply.papertrans.cn/71/7052/705194/705194_57.png

PAEAN 发表于 2025-3-31 13:47:13

http://reply.papertrans.cn/71/7052/705194/705194_58.png

Goblet-Cells 发表于 2025-3-31 18:06:03

Intraperitoneal Chemotherapy for Ovarian Cancerhe peritoneal cavity for much of its natural history, this approach seemed rational. Despite encouraging early results, the IP approach has not been incorporated into the mainstream management of advanced ovarian cancer.

aquatic 发表于 2025-3-31 23:25:00

Defective Apoptosis Underlies Chemoresistance in Ovarian Cancer the mechanisms that underlie chemoresistance is central to improving patient outcomes for ovarian cancer..The standard adjuvant therapy for ovarian cancer at this time is combination chemotherapy with a platinum-based drug and paclitaxel. The underlying principle of cancer therapy is the selective
页: 1 2 3 4 5 [6] 7
查看完整版本: Titlebook: Ovarian Cancer; State of the Art and George Coukos,Andrew Berchuck,Robert Ozols Conference proceedings 2008 The Editor(s) (if applicable) a